Michele Kang replaces John Textor as Lyon president
With the club's future on the line, there has been a crucial change in the hierarchy at Olympique Lyonnais. John Textor, who announced earlier this week that he would be stepping back from his role as president, has been replaced by Michele Kang.
The DNCG confirmed Lyon's relegation to Ligue 2 last week. The club announced that they would be appealing the decision. It was expected that, given his previous difficulties with French football's financial watchdog, Textor would be sidelined. 'I have shareholders to handle the issues that I haven't handled very well in France,' he admitted.
Gerlinger appointed Director General at Lyon
That has now come to pass with Kang coming in to replace Textor as OL president. Kang, the president of OL Lyonnes and a shareholder in Eagle Groupe, has now been appointed Chairman and CEO of Eagle Football Group and CEO of OL. Michael Gerlinger, meanwhile, has been appointed Director General.
Advertisement
'I'm grateful to everyone at OL for their dedication during this exceptionally challenging time. Michele is the perfect choice to lead OL in the next phase and I have full confidence in Michele and OL will come out stronger under her leadership,' said Textor in a press release.
GFFN | Luke Entwistle
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Report – France U21 Star To Undergo Inter Milan Medicals Tomorrow
Striker Ange-Yoan Bonny will undergo his medicals on a move from Parma to Inter Milan tomorrow. Italian outlet FCInterNews report that the 21-year-old will arrive in Milan today ahead of the move. Inter Milan have reportedly agreed a deal with Parma to sign striker Ange-Yoan Bonny. Advertisement The fee that the Nerazzurri will pay will be around €25 million including add-ons. Meanwhile, Bonny is to sign a five-year contract with Inter. Now there is the question of whether Ange-Yoan Bonny would be available for any of Inter's Club World Cup matches. Clearly, the Frenchman will not be available for Inter's next match. They take on Brazilian giants Fluminense in the round of sixteen tomorrow evening. Ange-Yoan Bonny To Undergo Inter Milan Medicals Tomorrow VENICE, ITALY – NOVEMBER 09: Ange-Yoan Bonny of Parma celebrates after scoring his team's second goal during the Serie A match between Venezia and Parma at Stadio Pier Luigi Penzo on November 09, 2024 in Venice, Italy. (Photo by) However, the wait for Bonny to sign won't be long, reports FCInterNews, The outlet anticipate that the Frenchman will be arriving in Milan this evening. Advertisement Then tomorrow, Bonny will undergo his medical exams with the Nerazzurri staff. Furthermore, FCIN report, Bonny will not undergo the typical exams on his athletic condition, as Inter consider those he already underwent with Parma sufficient. Then, Bonny can sign his contract and officially become an Inter Milan player.
Yahoo
29 minutes ago
- Yahoo
GeNeuro Announces Approval of All Resolutions Proposed at Extraordinary General Meeting
69.1% of the Company's share capital was represented at the EGM and resolutions were all unanimously approved GENEVA, Switzerland, June 30, 2025--(BUSINESS WIRE)--Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases, announces that its shareholders have approved all resolutions proposed at its Extraordinary General Meeting (EGM) of 30 June 2025. 69.1% of the Company's share capital was present or represented at the EGM and resolutions were all unanimously approved. Detailed results will be available on the Company's website at: As mentioned in the invitation to the EGM, in order to ensure continuity of governance, this Extraordinary General Meeting had been called to vote on the re-election of the members of the Board of Directors, the Chairman of the Board of Directors and the Remuneration Committee, as well as the independent representative, until the next Ordinary General Meeting can be held. Following his re-election to the Board, Mr Jesús Martin-Garcia has been named Executive Chairman of the Company. As previously announced, following the disappointing results of its last Phase 2 clinical trial in Long COVID, the Company has launched a major restructuring, making redundant all employees at the parent company level, seeking and obtaining a debt-restructuring moratorium and launching a major effort to monetize its assets. Despite the end of their employment contract at the end of December 2024, both Jesús Martin-Garcia and Mr Miguel Payró have agreed to continue on a part-time basis to support the Company's efforts as Executive Chairman and Chief Financial Officer respectively. As for the 2024 financial statements, in view of the uncertainty surrounding the outcome of the asset monetization process, the Company had announced that it suspended publication of its financial statements. About GeNeuro GeNeuro's mission is to develop safe and effective treatments against neurological disorders and autoimmune diseases, such as multiple sclerosis, by neutralizing causal factors encoded by HERVs, which represent 8% of human DNA. For more information, visit: Disclaimer: This press release contains certain forward - looking statements and estimates concerning GeNeuro's financial condition, operating results, strategy, projects and future performance and the markets in which it operates. Such forward-looking statements and estimates may be identified by words, such as "anticipate," "believe," "can," "could," "estimate," "expect," "intend," "is designed to," "may," "might," "plan," "potential," "predict," "objective," "should," or the negative of these and similar expressions. They incorporate all topics that are not historical facts. Forward looking statements, forecasts and estimates are based on management's current assumptions and assessment of risks, uncertainties and other factors, known and unknown, which were deemed to be reasonable at the time they were made but which may turn out to be incorrect. Events and outcomes are difficult to predict and depend on factors beyond the company's control. Consequently, the actual results, financial condition, performances and/or achievements of GeNeuro or of the industry may turn out to differ materially from the future results, performances or achievements expressed or implied by these statements, forecasts and estimates. Owing to these uncertainties, no representation is made as to the correctness or fairness of these forward-looking statements, forecasts and estimates. Furthermore, forward-looking statements, forecasts and estimates speak only as of the date on which they are made, and GeNeuro undertakes no obligation to update or revise any of them, whether as a result of new information, future events or otherwise, except as required by law. View source version on Contacts GeNeuro Jesús Martin-GarciaChairman and CEOinvestors@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
33 minutes ago
- Yahoo
Public invited to decide how MPs' pay should be set
Parliament's expenses watchdog wants around 20 members of the public to take part in a review of how it sets MPs' pay. The Independent Parliamentary Standards Authority (Ipsa) says the "citizens' forum" will help shape pay and expenses policy from next year onwards. The group will meet four times in September, and make recommendations alongside a wider online consultation expected to run until the autumn. Ipsa's review will also look at how the pay of British MPs compares to politicians in other countries. MPs' basic salary is currently £93,904, following a 2.8% annual rise in April. MPs' pay set to increase 2.8% to £93,904 in April Forum could examine assisted dying law - Labour The watchdog is legally mandated to review how it determines MPs' salaries and expenses following each general election. Previous reviews have used online consultations to gather views, but this is the first time members of the public have been asked to participate directly in the process. It is expected around 20 to 25 people will be recruited via a postal lottery of 10,000 addresses, with the aim of selecting a group that is broadly representative of the wider UK population. Those taking part will be asked to make recommendations to Ipsa's board as part of the review, which must conclude before April next year. Ipsa says those taking part must be aged 18 or over, and do not need any prior knowledge, or an interest in politics. The move is the latest example of a British body using a co-called citizens' assembly model when making a decision, following its widespread use in Ireland. It has previously been employed by the Scottish government to discuss constitutional questions after Brexit. Westminster committees have used it to decide recommendations on climate change and social care. Supporters say the model can help make decisions more democratic, although critics have questioned the extent to which panels of volunteers are ever able to reflect wider views in the broader population. The model had been tipped for wider government use after Sue Gray, Sir Keir Starmer's then chief of staff, said Labour would use it to decide contentious issues such as where houses should be built and how to reform the House of Lords. Ms Gray entered Downing Street after the election but was replaced after three months, and those plans appear to have been shelved. Ipsa was created in the wake of the 2009 expenses scandal to take on the task of setting MPs' pay, which was previously decided by MPs themselves. The watchdog does not currently have a set formula for deciding MPs' annual salaries. Instead, it says it balances data on public sector pay against the economic context, and pay in the "wider working population". In recent years it has experimented with linking annual awards, which take effect each April, to average public sector pay figures published the previous October. However, it has not always stuck rigidly to using this figure. In 2023, it recommended a higher pay rise for MPs, arguing the official data had failed to capture cost of living bonuses awarded elsewhere in the public sector. This year, it recommended a lower rise, by linking its 2.8% rise to initial Treasury plans for the public sector, which have since been increased after the government accepted a series of recommendations from pay review bodies last month. In a report published last year, Ipsa found that in 2023 British MPs were paid more than counterparts in countries including France and New Zealand. But they were paid less than equivalents in Ireland, Germany, Canada, Australia and the United States, the survey found. Sign up for our Politics Essential newsletter to read top political analysis, gain insight from across the UK and stay up to speed with the big moments. It'll be delivered straight to your inbox every weekday.
